The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels.
OBJECTIVE
To determine the effect of Helicobacter pylori (H. pylori) eradication on blood levels of high-sensitivity C-reactive protein (hs-CRP), macrophage migration inhibitory factor and fetuin-A in patients with dyspepsia who are concurrently infected with H. pylori.


METHODS
H.pylori infection was diagnosed based on the 14C urea breath test (UBT) and histology. Lansoprazole 30 mg twice daily, amoxicillin 1 g twice daily, and clarithromycin 500 mg twice daily were given to all infected patients for 14 days; 14C UBT was then re-measured. In 30 subjects, migration inhibitory factor, fetuin-A and hs-CRP levels were examined before and after the eradication of H. pylori infection and compared to levels in 30 healthy subjects who tested negative for H. pylori infection.


RESULTS
Age and sex distribution were comparable between patients and controls. Migration inhibitory factor and hs-CRP levels were higher, and fetuin-A levels were lower, in H. pylori-infected patients (p<0.05). Following eradication of H. pylori, migration inhibitory factor and hs-CRP levels were significantly decreased, whereas fetuin-A levels were increased. However, eradication of the organism did not change lipid levels (p>0.05).


CONCLUSIONS
These findings suggest that H. pylori eradication reduces the levels of pro-inflammatory cytokines such as migration inhibitory factor and hs-CRP and also results in a significant increase in anti-inflammatory markers such as fetuin-A.
Kebapcilar
Levent
L
Department of Internal Medicine, Izmir Bozyaka Training and Research Hospital, Izmir, Turkiye. leventkebapcilar@yahoo.com
Bilgir
Oktay
O
Cetinkaya
Elif
E
Akyol
Murat
M
Bilgir
Ferda
F
Bozkaya
Giray
G
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001798:Blood Proteins / Q000032:analysis*; D002097:C-Reactive Protein / Q000032:analysis*; D016022:Case-Control Studies; D004415:Dyspepsia / Q000188:drug therapy / Q000382:microbiology*; D016481:Helicobacter Infections / Q000097:blood* / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008263:Macrophage Migration-Inhibitory Factors / Q000097:blood*; D060749:alpha-2-HS-Glycoprotein
C556354:AHSG protein, human; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D001798:Blood Proteins; D008263:Macrophage Migration-Inhibitory Factors; D060749:alpha-2-HS-Glycoprotein; D002097:C-Reactive Protein